Capricor Therapeutics Stock Market Value
| CAPR Stock | USD 24.50 0.38 1.53% |
| Symbol | Capricor |
Can Biotechnology industry sustain growth momentum? Does Capricor have expansion opportunities? Factors like these will boost the valuation of Capricor Therapeutics. Projected growth potential of Capricor fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Capricor Therapeutics demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (1.72) | Revenue Per Share | Quarterly Revenue Growth (0.08) | Return On Assets | Return On Equity |
The market value of Capricor Therapeutics is measured differently than its book value, which is the value of Capricor that is recorded on the company's balance sheet. Investors also form their own opinion of Capricor Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Capricor Therapeutics' true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because Capricor Therapeutics' market value can be influenced by many factors that don't directly affect Capricor Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Capricor Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Capricor Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Capricor Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Capricor Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Capricor Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Capricor Therapeutics.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Capricor Therapeutics on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Capricor Therapeutics or generate 0.0% return on investment in Capricor Therapeutics over 90 days. Capricor Therapeutics is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Ainos, OSR Holdings, Lipocine, and SeaStar Medical. Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell a... More
Capricor Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Capricor Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Capricor Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.18 | |||
| Information Ratio | 0.1192 | |||
| Maximum Drawdown | 386.29 | |||
| Value At Risk | (8.29) | |||
| Potential Upside | 11.51 |
Capricor Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Capricor Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Capricor Therapeutics' standard deviation. In reality, there are many statistical measures that can use Capricor Therapeutics historical prices to predict the future Capricor Therapeutics' volatility.| Risk Adjusted Performance | 0.1002 | |||
| Jensen Alpha | 5.61 | |||
| Total Risk Alpha | 3.38 | |||
| Sortino Ratio | 0.8895 | |||
| Treynor Ratio | (2.36) |
Capricor Therapeutics February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1002 | |||
| Market Risk Adjusted Performance | (2.35) | |||
| Mean Deviation | 12.18 | |||
| Semi Deviation | 4.33 | |||
| Downside Deviation | 6.18 | |||
| Coefficient Of Variation | 832.14 | |||
| Standard Deviation | 46.1 | |||
| Variance | 2125.03 | |||
| Information Ratio | 0.1192 | |||
| Jensen Alpha | 5.61 | |||
| Total Risk Alpha | 3.38 | |||
| Sortino Ratio | 0.8895 | |||
| Treynor Ratio | (2.36) | |||
| Maximum Drawdown | 386.29 | |||
| Value At Risk | (8.29) | |||
| Potential Upside | 11.51 | |||
| Downside Variance | 38.16 | |||
| Semi Variance | 18.72 | |||
| Expected Short fall | (15.73) | |||
| Skewness | 7.9 | |||
| Kurtosis | 63.56 |
Capricor Therapeutics Backtested Returns
Capricor Therapeutics is very risky given 3 months investment horizon. Capricor Therapeutics secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 6.27% are justified by taking the suggested risk. Use Capricor Therapeutics Mean Deviation of 12.18, downside deviation of 6.18, and Risk Adjusted Performance of 0.1002 to evaluate company specific risk that cannot be diversified away. Capricor Therapeutics holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -2.34, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Capricor Therapeutics are expected to decrease by larger amounts. On the other hand, during market turmoil, Capricor Therapeutics is expected to outperform it. Use Capricor Therapeutics semi variance, and the relationship between the treynor ratio and daily balance of power , to analyze future returns on Capricor Therapeutics.
Auto-correlation | -0.66 |
Very good reverse predictability
Capricor Therapeutics has very good reverse predictability. Overlapping area represents the amount of predictability between Capricor Therapeutics time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Capricor Therapeutics price movement. The serial correlation of -0.66 indicates that around 66.0% of current Capricor Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.66 | |
| Spearman Rank Test | -0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 5.66 |
Pair Trading with Capricor Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Capricor Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Capricor Stock
Moving against Capricor Stock
| 0.86 | IMRN | Immuron Ltd ADR | PairCorr |
| 0.67 | EVGN | Evogene | PairCorr |
| 0.67 | GNLX | Genelux Common | PairCorr |
| 0.61 | EDIT | Editas Medicine | PairCorr |
| 0.54 | ABP | Abpro Holdings | PairCorr |
The ability to find closely correlated positions to Capricor Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Capricor Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Capricor Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Capricor Therapeutics to buy it.
The correlation of Capricor Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Capricor Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Capricor Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Capricor Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Capricor Stock Analysis
When running Capricor Therapeutics' price analysis, check to measure Capricor Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Capricor Therapeutics is operating at the current time. Most of Capricor Therapeutics' value examination focuses on studying past and present price action to predict the probability of Capricor Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Capricor Therapeutics' price. Additionally, you may evaluate how the addition of Capricor Therapeutics to your portfolios can decrease your overall portfolio volatility.